InvestLog
CRNX logo

CRNX

Crinetics Pharmaceuticals, Inc.NASDAQHealthcare
$37.23+1.80%ClosedMarket Cap: $3.90B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-02Citizens—Market Outperform—
2026-01-12Goldman Sachs—Buy—
2026-01-08Citizens—Market Outperform—
2026-01-06Morgan Stanley—Overweight—
2025-11-07Citizens—Market Outperform—
2025-09-30Oppenheimer—Outperform—
2025-09-29Leerink Partners—Outperform—
2025-09-29Morgan Stanley—Overweight—
2025-09-26Baird—Outperform—
2025-09-26Goldman Sachs—Neutral—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-4.13$176.1M9
Sun Dec 31$-2.47$418.2M5
Mon Dec 31$0.95$933.1M1
Tue Dec 31$4.93$1.59B1